Condition: Parkinson Disease · Depression · PARKINSON DISEASE (Disorder) · Sponsor: University of British Columbia
This study evaluates the use of an oral multi-strain probiotic in the treatment of depression in individuals with Parkinson's Disease. Participants will be randomized to either a 12-week multi-strain probiotic treatment or placebo intervention.
This description comes directly from the study's public registry record.
Matthew Leung, BSc · 604-827-1905 · Matthew.Leung@ubc.ca
Annie Kuan · 604-827-0576 · annie.kuan@ubc.ca
Always discuss trial participation with your own doctor first.
| Pacific Parkinson's Research Centre | Vancouver, British Columbia, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05568498